Find out more about Mark Waltham's experience
Mark Waltham's highlights
Mark Waltham's selected work
Epithelial - Mesenchymal Interconversions In The Breast Cancer Metastatic Cascade
Internal Research Grant
Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast..
Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of M..
Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasiv..
Displaying the 2 most recent projects by Mark Waltham.
Displaying the 23 most recent scholarly works by Mark Waltham.
Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts
Anthony Tachtsidis, Anh Viet-Phuong Le, Tony Blick, Devika Gunasinghe, Emma De Sousa, Mark Waltham, Alex Dobrovic, Erik W Thompson
Journal article | 2019 | Clinical & Experimental Metastasis
Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
HJ Hugo, NPAD Gunasinghe, BG Hollier, T Tanaka, T Blick, A Toh, P Hill, C Gilles, M Waltham, EW Thompson
Journal article | 2017 | Breast Cancer Research
Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis
Cecilia W Huo, Mark Waltham, Christine Khoo, Stephen B Fox, Prue Hill, Shou Chen, Grace L Chew, John T Price, Chau H Nguyen, Elizabeth D Williams, Michael Henderson, Erik W Thompson, Kara L Britt
Journal article | 2016 | Breast Cancer Research
Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines
J Cursons, KJ Leuchowius, M Waltham, E Tomaskovic-Crook, M Foroutan, CP Bracken, A Redfern, EJ Crampin, I Street, MJ Davis, EW Thompson
Journal article | 2015 | Cell Communication and Signaling
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor
Theodora Fifis, Linh Nguyen, Cathy Malcontenti-Wilson, Lie Sam Chan, Patricia Luiza Nunes Costa, Jurstine Daruwalla, Mehrdad Nikfarjam, Vijayaragavan Muralidharan, Mark Waltham, Erik W Thompson, Christopher Christophi
Journal article | 2013 | Cancer Medicine
An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer
Manisha Shah, Dexing Huang, Tony Blick, Andrea Connor, Lawrence A Reiter, Joel R Hardink, Conor C Lynch, Mark Waltham, Erik W Thompson
Journal article | 2012 | PLoS One
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44(hi/)CD24(lo/-) Stem Cell Phenotype in Human Breast Cancer
Tony Blick, Honor Hugo, Edwin Widodo, Mark Waltham, Cletus Pinto, Sendurai A Mani, Robert A Weinberg, Richard M Neve, Marc E Lenburg, Erik W Thompson
Journal article | 2010 | Journal of Mammary Gland Biology and Neoplasia
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line
JT Price, JMW Quinn, NA Sims, J Vieusseux, K Waldeck, SE Docherty, D Myers, A Nakamura, MC Waltham, MT Gillespie, EW Thompson
Journal article | 2005 | Cancer Research
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice
JA Sharp, M Waltham, ED Williams, MA Henderson, EW Thompson
Journal article | 2004 | Clinical and Experimental Metastasis
Surgery - St Vincent'S Hospital